Literature DB >> 3777691

Deposition, clearance, and effects of aerosolized amiloride in sheep airways.

W M Mentz, J B Brown, M Friedman, M J Stutts, J T Gatzy, R C Boucher.   

Abstract

Persistent Na+ absorption across a relatively Cl- impermeable epithelial barrier may contribute to the smaller water content of airway surface liquid (ASL) in cystic fibrosis. In this study, the feasibility and effectiveness of delivering an inhibitor of Na+ absorption, amiloride, by aerosol to the ASL of awake sheep was evaluated. Aerosolization of 6 X 10(-3) M amiloride, with [14C]amiloride, resulted in an estimated concentration of 7 X 10(-4) M in ASL. The transtracheal electric potential difference (PD), an index of the rate of Na+ absorption, was significantly inhibited (-29%) immediately after aerosolization of amiloride. The inhibition was short-lived and was correlated with rapid disappearance of the drug from ASL (half-time, 10.5 min between 0 and 30 min after aerosolization). Amiloride but not aerosol vehicle increased ASL volume significantly. The unidirectional flow of [14C]amiloride from the lumen to the submucosa across excised, short-circuited sheep airways exceeded flow from submucosa to lumen by a factor of at least 6. This finding suggests that amiloride is actively absorbed and is consistent with the rapid clearance from the airway surface and the short-lived effects of aerosolized amiloride in vivo. We conclude that sufficient concentrations of amiloride can be delivered to sheep airways by aerosol to inhibit PD and Na+ absorption for short periods.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777691     DOI: 10.1164/arrd.1986.134.5.938

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.

Authors:  R C Cohn; M Jacobs; S C Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Drug Therapy in the 1990s : What Can We Expect for Cystic Fibrosis?

Authors:  Richard C Boucher
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  New respiratory therapies in cystic fibrosis.

Authors:  D E Stableforth
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

4.  Fluid and electrolyte transport by cultured human airway epithelia.

Authors:  J J Smith; M J Welsh
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Influence of Inhaled Amiloride on Lung Fluid Clearance in Response to Normobaric Hypoxia in Healthy Individuals.

Authors:  Courtney M Wheatley; Sarah E Baker; Bryan J Taylor; Manda L Keller-Ross; Steven C Chase; Alex R Carlson; Robert J Wentz; Eric M Snyder; Bruce D Johnson
Journal:  High Alt Med Biol       Date:  2017-09-06       Impact factor: 1.981

6.  In vivo airway surface liquid Cl- analysis with solid-state electrodes.

Authors:  Ray A Caldwell; Barbara R Grubb; Robert Tarran; Richard C Boucher; Michael R Knowles; Pierre M Barker
Journal:  J Gen Physiol       Date:  2002-01       Impact factor: 4.086

7.  Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.

Authors:  P G Middleton; D M Geddes; E W Alton
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

8.  Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.

Authors:  S H Thomas; M J O'Doherty; A Graham; C J Page; P Blower; D M Geddes; T O Nunan
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.